Physician profile
Thomas Roberts
NPI 1508858036
$10,435.33
in general payments reported to CMS, 2019-2025
15 companies · $29.46 in 2025
The $29.46 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,611 · 2020: $1,049 · 2021: $2,718 · 2022: $4,098 · 2023: $333 · 2024: $598 · 2025: $29.46.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $562 · Food and Beverage: $399.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $561.58 |
| Food and Beverage | $398.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Midsouth Orthopedics INC. | $6,231.98 | 2019-2022 | |
| Arthrex, INC. | $3,817.02 | 2019-2024 | |
| Integra Lifesciences Corporation | $71.69 | 2024 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Baudax Bio INC. | $54.05 | 2020 | |
| Smith+Nephew, INC. | $53.34 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $42.90 | 2024 | |
| Bioventus LLC | $29.46 | 2025 | Exogen Ultrasound Bone Healing System, Durolane |
| Anika Therapeutics, INC. | $28.49 | 2023 | X-Twist, Ovomotion |
| Pacira Therapeutics, INC. | $23.34 | 2021 | |
| Pacira Pharmaceuticals Incorporated | $19.00 | 2022 | |
| Zimmer Biomet Holdings, INC. | $18.17 | 2023 | Xtrafix |
| Ethicon US, LLC | $16.65 | 2020 | |
| Convatec INC. | $12.84 | 2019 | |
| Zyla Life Sciences, INC. | $11.84 | 2020 | |
| Kinex Medical Company LLC | $4.56 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Roberts listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.